US Patent 11571518 | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Find Prospects
- Prospector
Drugs in Dev.
News
Blog
Market Place
Login

U.S. Patents

PharmaCompass Sponsored Ads

Post An Enquiry

Evonik Health Care is the innovation hub for leading life science companies

Contact Supplier

Aarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.

Contact Supplier

PharmaCompass Sponsored Ads

Post An Enquiry

Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

Contact Supplier

pharmacompass-2-2026-02-09

Xls

CATEGORY PAGE

Filters

FILTER :

filter Applicant Reset all filters

3 All

01 3ZMI PHARMA

filter Patent Number Reset all filters

3 All

01 311571518

API Patent Reset all filters

3 All

01 3Blank

filter FDF Patent Reset all filters

3 All

01 3Y

filter Expiration Date Reset all filters

3 All

01 32041-06-14

01

ZMI PHARMA

NALOXONE HYDROCHLORIDE

BioProcess International US West

Not Confirmed

ZMI PHARMA

Country

BioProcess International US West

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2041-06-14

NALOXONE HYDROCHLORIDE

US Patent Number : 11571518

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 212854

Patent Use Code : U-3517

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2041-06-14

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

ZMI PHARMA

NALOXONE HYDROCHLORIDE

BioProcess International US West

Not Confirmed

ZMI PHARMA

Country

BioProcess International US West

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2041-06-14

NALOXONE HYDROCHLORIDE

US Patent Number : 11571518

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 212854

Patent Use Code : U-3516

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2041-06-14

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

ZMI PHARMA

NALOXONE HYDROCHLORIDE

BioProcess International US West

Not Confirmed

ZMI PHARMA

Country

BioProcess International US West

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2041-06-14

NALOXONE HYDROCHLORIDE

US Patent Number : 11571518

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 212854

Patent Use Code : U-3515

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2041-06-14

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.